Unlike conventional stem cell transplantation, the purpose of microtransplantation is to achieve microchimerism, a process to allow the donor's peripheral blood stem cells
(PBSCs) to be "planted" in the recipient's body in a very small amount.
A drug causes more HSCs to leaves the bone marrow and enter the blood stream, which allows large number of peripheral blood stem cells
(PBSCs) to be collected.
The Japanese call for collection of the peripheral blood stem cells
of the workers is to prepare them for future transplants, should the need arise.
For the actual donation, the patient's doctor will choose between two methods, based on what's best for the patient: bone marrow (a surgical procedure performed in a hospital with general or regional anesthesia) or peripheral blood stem cells
(an outpatient procedure similar to donating plasma).
In 1999 the first SABMR donor provided peripheral blood stem cells
to a South African patient.
Over the years, BMT has evolved from transplanting stem cell sources of bone marrow for the treatment of leukemia and lymphoma to using umbilical cord blood and peripheral blood stem cells
for a broader array of diseases, including multiple myeloma, aplastic anemia, myelodysplasia, immunodeficiency diseases, hemoglobinopathies, Fanconi anemia, and inborn errors of metabolism.
I assume that this case involved adult stem cells, since the ``donor agreed to give peripheral blood stem cells
to the young man.
Since the 1960s, scientists have successfully infused bone marrow or peripheral blood stem cells
into patients, but investigating new methods to utilize stem cells is an intense focus of scientific inquiry.
Results Indicate Bone Marrow Reduces Risk of Graft-Versus-Host Disease Compared to Peripheral Blood Stem Cells
Tanimoto and Taniguchi stressed that the worker's own peripheral blood stem cells
should be used in case of future transplant needs.
Use of peripheral blood stem cells
replacing traditional bone marrow and use of double cord blood transplantation
This source will provide consulting services as it relates to securing loans, letters of credit, and/or debt based facilities for the acquisition of equipment necessary for the cryopreservation of adipose tissue, umbilical cord blood stem cells and peripheral blood stem cells